HIV-ASSOCIATED TUBERCULOSIS

Clinical trials for HIV-ASSOCIATED TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new HIV-ASSOCIATED TUBERCULOSIS trials appear

Sign up with your email to follow new studies for HIV-ASSOCIATED TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Double-Dose HIV drug tested to fight tuberculosis combo

Disease control Completed

This study tested whether giving a double dose of the HIV medication dolutegravir is safe and effective when taken alongside a specific tuberculosis (TB) treatment regimen. Researchers enrolled 30 adults with both HIV and newly diagnosed TB to see if the adjusted dosing would mai…

Matched conditions: HIV-ASSOCIATED TUBERCULOSIS

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

HIV-ASSOCIATED TUBERCULOSIS

Get alerted when new HIV-ASSOCIATED TUBERCULOSIS trials appear

Double-Dose HIV drug tested to fight tuberculosis combo